Your shopping cart is currently empty

D1R antagonist 2 (Compound 13a) is a blood-brain barrier-permeable D1R antagonist, with IC50 values of 35.6 nM for cAMP-based D1R and 70 nM for β-arrestin-based D1R. It effectively inhibits D1R-mediated cAMP and β-arrestin recruitment and is applicable in studies of neurodegenerative and neuropsychiatric disorders, such as schizophrenia, Parkinson's disease, and Alzheimer's disease.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | D1R antagonist 2 (Compound 13a) is a blood-brain barrier-permeable D1R antagonist, with IC50 values of 35.6 nM for cAMP-based D1R and 70 nM for β-arrestin-based D1R. It effectively inhibits D1R-mediated cAMP and β-arrestin recruitment and is applicable in studies of neurodegenerative and neuropsychiatric disorders, such as schizophrenia, Parkinson's disease, and Alzheimer's disease. |
| Targets&IC50 | D1 Receptor:35.6 (cAM nM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.